
Maharishi V. Khirodhar
Examiner (ID: 10559, Phone: (571)270-7909 , Office: P/2463 )
| Most Active Art Unit | 2463 |
| Art Unit(s) | 2463, 2416 |
| Total Applications | 881 |
| Issued Applications | 739 |
| Pending Applications | 63 |
| Abandoned Applications | 97 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7033184
[patent_doc_number] => 20050031693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials'
[patent_app_type] => utility
[patent_app_number] => 10/910448
[patent_app_country] => US
[patent_app_date] => 2004-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25790
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10910448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/910448 | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials | Aug 2, 2004 | Issued |
Array
(
[id] => 7345876
[patent_doc_number] => 20040247684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Proteins stabilized with polysaccharide gums'
[patent_app_type] => new
[patent_app_number] => 10/494068
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7867
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20040247684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494068
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494068 | Proteins stabilized with polysaccharide gums | Jul 20, 2004 | Abandoned |
Array
(
[id] => 5793199
[patent_doc_number] => 20060013880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Formulation stabilizer for proton pump inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/893489
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4322
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20060013880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10893489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/893489 | Formulation stabilizer for proton pump inhibitors | Jul 18, 2004 | Abandoned |
Array
(
[id] => 5887754
[patent_doc_number] => 20060275339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Use of antiseptic active principles in pmma bone cements'
[patent_app_type] => utility
[patent_app_number] => 10/564372
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 810
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564372
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564372 | Use of antiseptic active principles in pmma bone cements | Jul 15, 2004 | Abandoned |
Array
(
[id] => 9950533
[patent_doc_number] => 08999315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Bis-quaternary ammonium salt corrosion inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/891575
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3253
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10891575
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891575 | Bis-quaternary ammonium salt corrosion inhibitors | Jul 14, 2004 | Issued |
Array
(
[id] => 7250165
[patent_doc_number] => 20050074425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Method for delivering polymerized therapeutic agent compositions and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 10/884226
[patent_app_country] => US
[patent_app_date] => 2004-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 10393
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10884226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/884226 | Method for delivering polymerized therapeutic agent compositions and compositions thereof | Jul 1, 2004 | Abandoned |
Array
(
[id] => 6977481
[patent_doc_number] => 20050287198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Phospholipid gel compositions for drug delivery and methods of treating conditions using same'
[patent_app_type] => utility
[patent_app_number] => 10/874532
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18972
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287198.pdf
[firstpage_image] =>[orig_patent_app_number] => 10874532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/874532 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same | Jun 23, 2004 | Issued |
Array
(
[id] => 8102929
[patent_doc_number] => 08153111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Photo-triggered release of active substances from dendrimer-photosensitizer complexes'
[patent_app_type] => utility
[patent_app_number] => 10/871676
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3848
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10871676
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/871676 | Photo-triggered release of active substances from dendrimer-photosensitizer complexes | Jun 17, 2004 | Issued |
Array
(
[id] => 161687
[patent_doc_number] => 07670594
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-03-02
[patent_title] => 'Hair and skin conditioning compositions'
[patent_app_type] => utility
[patent_app_number] => 10/867999
[patent_app_country] => US
[patent_app_date] => 2004-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3851
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/670/07670594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10867999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/867999 | Hair and skin conditioning compositions | Jun 15, 2004 | Issued |
Array
(
[id] => 7034317
[patent_doc_number] => 20050032827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Sigma ligands for neuronal regeneration and functional recovery'
[patent_app_type] => utility
[patent_app_number] => 10/868267
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12411
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032827.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868267
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868267 | Sigma ligands for neuronal regeneration and functional recovery | Jun 13, 2004 | Abandoned |
Array
(
[id] => 7082706
[patent_doc_number] => 20050048086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 10/863864
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14851
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048086.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863864 | Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation | Jun 7, 2004 | Abandoned |
Array
(
[id] => 7265052
[patent_doc_number] => 20040242588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Compounds, formulations, and methods for treating or preventing rosacea'
[patent_app_type] => new
[patent_app_number] => 10/853585
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9617
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242588.pdf
[firstpage_image] =>[orig_patent_app_number] => 10853585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/853585 | Compounds, formulations, and methods for treating or preventing rosacea | May 24, 2004 | Issued |
Array
(
[id] => 7295142
[patent_doc_number] => 20040213843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Pharmaceutical formulation of gepirone for oral administration'
[patent_app_type] => new
[patent_app_number] => 10/852733
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1803
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20040213843.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852733
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852733 | Pharmaceutical formulation of gepirone for oral administration | May 23, 2004 | Abandoned |
Array
(
[id] => 4484642
[patent_doc_number] => 07883722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Controlled release composition'
[patent_app_type] => utility
[patent_app_number] => 10/845522
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5521
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/883/07883722.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845522 | Controlled release composition | May 13, 2004 | Issued |
Array
(
[id] => 7384155
[patent_doc_number] => 20040180095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Treatment of inoperable turmors by stereotactic injection of microspheres'
[patent_app_type] => new
[patent_app_number] => 10/451216
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4634
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451216 | Treatment of inoperable turmors by stereotactic injection of microspheres | Apr 27, 2004 | Abandoned |
Array
(
[id] => 4459001
[patent_doc_number] => 07879357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients'
[patent_app_type] => utility
[patent_app_number] => 10/833273
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13083
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879357.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833273 | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients | Apr 27, 2004 | Issued |
Array
(
[id] => 5624796
[patent_doc_number] => 20060263301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'In situ gelling self-reactive materials for embolization'
[patent_app_type] => utility
[patent_app_number] => 10/554046
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16780
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554046 | In situ gelling self-reactive materials for embolization | Apr 25, 2004 | Issued |
Array
(
[id] => 7060652
[patent_doc_number] => 20050003013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Drug'
[patent_app_type] => utility
[patent_app_number] => 10/829243
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6276
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10829243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/829243 | Drug | Apr 21, 2004 | Abandoned |
Array
(
[id] => 7181433
[patent_doc_number] => 20040202693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem'
[patent_app_type] => new
[patent_app_number] => 10/822949
[patent_app_country] => US
[patent_app_date] => 2004-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2627
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20040202693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10822949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/822949 | Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem | Apr 12, 2004 | Abandoned |
Array
(
[id] => 7250030
[patent_doc_number] => 20040258750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof'
[patent_app_type] => new
[patent_app_number] => 10/818666
[patent_app_country] => US
[patent_app_date] => 2004-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5460
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10818666
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/818666 | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof | Apr 5, 2004 | Abandoned |